DURECT CORPORATION

NASDAQ: DRRX (DURECT Corporation)

Last update: 18 hours ago
Inactive

0.000

0.00 (0.00%)

Price / Sales 35.78
Price / Book 17.03
Profit Margin -264.71%
Operating Margin (TTM) -1,289.41%
Diluted EPS (TTM) -0.480
Quarterly Revenue Growth (YOY) -35.30%
Total Debt/Equity (MRQ) 37.06%
Current Ratio (MRQ) 1.23
Operating Cash Flow (TTM) -15.86 M
Levered Free Cash Flow (TTM) -7.19 M
Return on Assets (TTM) -41.39%
Return on Equity (TTM) -217.95%

Market Trend

Short Term Medium Term
Industry Drug Manufacturers - Specialty & Generic (US) Mixed Mixed
Drug Manufacturers - Specialty & Generic (Global) Mixed Mixed
Stock DURECT Corporation Mixed Mixed

AIStockmoo Score

0.5
Analyst Consensus NA
Insider Activity NA
Price Volatility 3.0
Technical Moving Averages 0.0
Technical Oscillators 0.0
Relative Valuation NA
Financial Health -2.5
AI Insight NA
Weighted Average 0.50

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
DRRX - - - 17.03
RGC 5 B - - 2.43
SUPN 2 B - - 2.45
ANIP 2 B - 15.95 2.86
PCRX 1 B - 103.83 1.46
AMPH 1 B - 15.41 1.38

Select this tab to load the latest available analysis.

Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the Europe .

Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Investment Style Small Value
% Held by Insiders 11.82%
% Held by Institutions 22.32%

No data within this time range.

No data within this time range.

AI Technical Analysis

Open the Technical tab to generate the latest analysis.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2026 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria